Getting Serious about High U.S. Drug Prices

The U.S. pharma industry is under attack by executive order, with the latest salvo designed to ensure the Medicare Part B program pays the same price for drugs as similarly developed nations pay. That order joins others issued this summer, all aimed at high U.S. drug prices. These orders – all variants of previous orders and […]

Read More

Health Insurers Need BPaaS to Weather Post-Pandemic Conditions (First of a Multipart Series)

If you believe the headlines, health insurers are enjoying surging profits that have exceeded forecasted levels, even as other healthcare sectors struggle amid the COVID-19 pandemic. Most of these overly rosy assessments overlook short-term factors such as how rising unemployment numbers could reduce revenues from plan premiums. Even more important, these reports don’t reflect the […]

Read More
X Close